Skip to main content

Table 2 Clinical data between case group and control group

From: Alteration in the mRNA expression profile of the autophagy-related mTOR pathway in schizophrenia patients treated with olanzapine

 

Case group (n = 45)

Control group (n = 46)

t /χ2 test (p)

Age, Mean (SD)

38.20 (11.72)

36.78 (10.96)

0.596 (0.553)

Male, N (%)

22 (48.9)

27 (58.7)

0.530 (0.467)

Education, Mean (SD)

10.56 (3.71)

11.38 (4.69)

0.924 (0.358)

Married, N (%)

20 (44.4)

24 (52.1)

0.114 (0.736)

Onset age, Mean (SD)

31.22 (11.26)

NA

NA

First-episode patients, N (%)

15 (33.3)

NA

NA

Disease duration (years), Mean (SD)

2.80 (1.91)

NA

NA

Olanzapine dose (mg/d), Mean (SD)

14.24 (4.35)

NA

NA

PANSS score, Mean (SD)

 Before treatment

115.84 (15.64)

NA

NA

 After treatment

76.38 (14.72)

NA

NA

  1. Note: The data of sex and marital status were compared with χ2 test, and the data of age and years of education was compared with t test. The data of sex, age, marital status and years of education had no significant difference between the case group and control group (p>0.05)